IMPORTANT INVESTOR ALERT: Lundin Law PC Announces an Investigation of Neos Therapeutics, Inc. and Advises Investors with Losses
to Contact the Firm
Lundin Law PC (http://lundinlawpc.com/) announces that it is investigating claims against Neos Therapeutics, Inc. (“Neos” or
the “Company”) (Nasdaq: NEOS) concerning possible violations of federal securities laws.
To get more information about this investigation, please contact Brian Lundin, Esquire, of Lundin Law PC, at 888-713-1033, or
via email at brian@lundinlawpc.com.
The investigation focuses on the Company’s August 11, 2016 announcement of its financial results for the second quarter of 2016,
reporting that Neos missed its earnings expectations by $0.49 per share. When this news was announced, the Neos stock price
fell.
Lundin Law PC was founded by Brian Lundin, a securities litigator based in Los Angeles dedicated to upholding shareholders’
rights.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Lundin Law PC
Brian Lundin, Esq.
Telephone: 888-713-1033
Facsimile: 888-713-1125
brian@lundinlawpc.com
http://lundinlawpc.com/
View source version on businesswire.com: http://www.businesswire.com/news/home/20160919006347/en/